ARUK2010694
ARUK2010694 (Compound 20) is a potent and selective NUAK1 inhibitor with a pIC50 of 8.7. ARUK2010694 also inhibits CDK2, CDK4 and CDK6 activity, with inhibitory rate of 13%, 63% and 32% at 1 μM. ARUK2010694 can be used for the research of neurological disease, such as Alzheimer’s disease (AD).
For research use only. We do not sell to patients.
- Formula: C26H37N7O2
- Molecular Weight:479.62
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
All AMPK Isoforms
More
Biological Activity
Description
IC50 & Target
[1]|
NUAK1 8.7 (pIC50) |
CDK2 |
CDK4 |
CDK6 |
Parmacokinetics
| Species | Dose | Route | T1/2 | AUCinf | Brain-to-Plasma Ratio |
|---|---|---|---|---|---|
| Mice[1] | 5 mg/kg | i.p. | 1.6 h | 1015 ng·h/mL | 0.1/0.2 |
Chemical Information
-
Molecular Weight 479.62
-
Formula C26H37N7O2
-
SMILES
CC(N1CCN(C2=CC=C(NC3=NC(OCC4CC(C)(C)OCC4)=C5N=CNC5=N3)C=C2)CC1)C
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Research Protocol for Neurological Diseases
PINK1/Parkin-mediated mitophagy pathway is a mitochondrial quality-control signaling axis in which mitochondrial depolarization stabilizes PINK1 on damaged mitochondria, activates Parkin recruitment and E3 ubiquitin ligase activity, promotes ubiquitination of outer mitochondrial membrane proteins, recruits selective autophagy adaptors, and drives lysosomal degradation of damaged mitochondria. In neurological disease research, this pathway is experimentally important because neurons, especially dopaminergic neurons, are highly dependent on mitochondrial integrity, and defective mitochondrial turnover can lead to mitochondrial dysfunction, oxidative stress, impaired neuronal survival, α-synuclein accumulation, and neuroinflammatory damage-associated signals. The genetic disease link is strongest in Parkinson’s disease because mutations in PRKN/parkin cause autosomal recessive juvenile parkinsonism, mutations in PINK1 cause hereditary early-onset Parkinson’s disease, and Drosophila studie
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)